Researchers take key step toward new treatment for hereditary blindness
Scientists from the Oregon State University (OSU) School of Pharmacy in the United States have demonstrated the possibility of using lipid nanoparticles and messenger RNA in animals, the technology on which COVID-19 vaccines are basedto treat blindness associated with a rare genetic disease. The researchers developed nanoparticles capable of penetrating the neural retina and administer mRNA to the photoreceptor cells whose proper functioning makes vision possible, as published in the journal 'Science Advances'. The study, led by OSU Associate Professor of Pharmaceutical Sciences Gaurav Sahay, Oregon State doctoral student Marco Herrera-Barrera, and Oregon Health & Science University Assistant Professor of…
